Prognostication of thrombotic and hemorrhagic events in patients hospitalized with novel coronavirus infection COVID-19
- 作者: Korshunova A.A.1, Kulikov A.N.1, Trofimov V.I.1, Teplov V.M.1, Kovalchuk Y.P.1, Kadinskaya M.I.1, Ginzburg A.M.1, Lapin S.V.1
-
隶属关系:
- Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
- 期: 卷 8, 编号 6 (2022)
- 页面: 41-53
- 栏目: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/289142
- DOI: https://doi.org/10.18565/therapy.2022.6.41-53
- ID: 289142
如何引用文章
详细
全文:
作者简介
Alexandra Korshunova
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russiadeputy chief physician for clinical and expert work
Alexander Kulikov
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of RussiaDr. med. habil., professor, head of the Department of propaedeutics of internal diseases with the clinic, head of the Department of functional diagnostics, deputy chief physician of the clinic for the medical part (therapy)
Vasily Trofimov
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of RussiaDr. med. habil., professor, head of the Department of hospital therapy with the course of allergology and immunology named after academician M.V. Chernorutsky with the clinic
Vadim Teplov
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of RussiaDr. med. habil., associate professor, head of the Department of emergency of Research Institute of Surgery and Emergency Medicine
Yuri Kovalchuk
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: yuriikowalchuk@yandex.ru
PhD in Medicine, deputy chief physician of the clinic for laboratory diagnostics
Margarita Kadinskaya
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: mkadinskaya@mail.ru
PhD in Medicine, associate professor of Department of clinical laboratory diagnostics
Alexander Ginzburg
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: ginzalex@yandex.ru
PhD in Medicine, head of the laboratory - doctor of clinical laboratory diagnostics of the laboratory of preanalytical modification of biomaterial of the department of laboratory diagnostics
Sergei Lapin
Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: svlapin@mail.ru
PhD in Medicine, head of the Laboratory for diagnostics of autoimmune diseases of the Scientific and Methodological Center for molecular medicine of the Ministry of Healthcare of Russia
参考
- Gerber G.F., Chaturvedi S. How to recognize and manage COVID-19-associated coagulopathy. Hematology Am Soc Hematol Educ Program. 2021; 2021(1): 614-20. https://dx.doi.org/10.1182/hematology.2021000297.
- Song J.C., Wang G., Zhang W. et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020; 7(1): 19. https://dx.doi.org/10.1186/s40779-020-00247-7.
- Salabei J.K., Fishman T.J., Asnake Z.T. et al. COVID-19 coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung. 2021; 50(2): 357-60. https://dx.doi.org/10.1016/j.hrtlng.2021.01.011.
- Zhang S., Li Y., Liu G., Su B. Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis. Thromb J. 2021; 19(1): 91. https://dx.doi.org/10.1186/s12959-021-00343-1.
- Monfardini L., Morassi M., Botti P. et al. Pulmonary thromboembolism in hospitalised COVID-19 patients at moderate to high risk by Wells score: A report from Lombardy, Italy. Br J. Radiol. 2020; 93(1113): 20200407. https://dx.doi.org/10.1259/bjr.20200407.
- Schulman S., Hu Y., Konstantinides S. Venous thromboembolism in COVID-19. Thromb Haemost. 2020; 120(12): 1642-53. https://dx.doi.org/10.1055/s-0040-1718532.
- Olesen J.B., Torp-Pedersen C., Hansen M.L., Lip G.Y. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: A nationwide cohort study. Thromb Haemost. 2012; 107(6): 1172-79. https://dx.doi.org/10.1160/TH12-03-0175.
- Geersing G.J., Zuithoff N.P., Kearon C. et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: Individual patient data meta-analysis. BMJ. 2014; 348: g1340. https://dx.doi.org/10.1136/bmj.g1340.
- Le Gal G., Righini M., Roy P.M. et al. Prediction of pulmonary embolism in the emergency department: The revised Geneva score. Ann Intern Med. 2006; 144(3): 165-71. https://dx.doi.org/10.7326/0003-4819-144-3-200602070-00004.
- Kandagatla P., Goranta S., Antoine H. et al. PADUA score as a predictor for pulmonary embolism: a potential strategy for reducing unnecessary imaging. J. Thromb Thrombolysis. 2019; 47(4): 566-71. https://dx.doi.org/10.1007/s11239-018-01801-w.
- Gibson C.M., Spyropoulos A.C., Cohen A.T. et al. The IMPROVEDD VTE risk score: incorporation of D-Dimer into the IMPROVE score to improve venous thromboembolism risk stratification. TH open. 2017; 1(1): e56-e65. https://dx.doi.org/10.1055/s-0037-1603929.
- Fang M.C., Go A.S., Chang Y. et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J. Am Coll Cardiol. 2011; 58(4): 395-401. https://dx.doi.org/10.1016/j.jacc.2011.03.031.
- Laursen S.B., Hansen J.M., de Muckadell O.B.S. The Glasgow Blatchford score is the most accurate assessment of patients with upper gastrointestinal hemorrhage. Clin Gastroenterol Hepatol. 2012; 10(10): 1130-35.e1. https://dx.doi.org/10.1016/jxgh.2012.06.022.
- Pisters R., Lane D.A., Nieuwlaat R. et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138(5): 1093-100. https://dx.doi.org/10.1378/chest.10-0134.
- Apostolakis S., Lane D.A., Guo Y. et al. Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED bleeding risk - prediction scores in nonwarfarin anticoagulated atrial fibrillation patients. J. Am Coll Cardiol. 2013; 61(3): 386-87. https://dx.doi.org/10.1016/j.jacc.2012.10.010.
- O'Brien E.C., Simon D.N., Thomas L.E. et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015; 36(46): 3258-64. https://dx.doi.org/10.1093/eurheartj/ehv476.
- Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 9 (26.10.2020). Минздрав России. Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/548/original/%D0%9C%D0%A0_COVID-19_%28v.9%29.pdf (дата обращения - 28.07.2022).
- Rindi L.V., Al Moghazi S., Donno D.R. et al. Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic review. Int J. Infect Dis. 2022; 115: 93-100. https://dx.doi.org/10.1016/j.ijid.2021.11.038.
- Mestre-Gomez B., Lorente-Ramos R.M., Rogado J. et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J. Thromb Thrombolysis. 2021; 51(1): 40-46. https ://dx.doi.org/10.1007/s11239-020-02190-9.
- Garcia-Ortega A., Oscullo G., Calvillo P. et al. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection. J. Infect. 2021; 82(2): 261-69. https://dx.doi.org/10.1016/j.jinf.2021.01.003.
- Zhan H., Chen H., Liu C. et al. Diagnostic value of D-dimer in COVID-19: A meta-analysis and meta-regression. Clin Appl Thromb Hemost. 2021; 27: 10760296211010976. https://dx.doi.org/10.1177/10760296211010976.
- Ahmed S., Jafri L., Hoodbhoy Z., Siddiqui I. Prognostic value of serum procalcitonin in COVID-19 patients: A systematic review. Indian J. Crit Care Med. 2021; 25(1): 77-84. https://dx.doi.org/10.5005/jp-journals-10071-23706.
- Bonaventura A., Vecchie A., Dagna L. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID- 19. Nat Rev Immunol. 2021; 21(5): 319-29. https://dx.doi.org/10.1038/s41577-021-00536-9.
- Roncon L., Zuin M., Barco S. et al. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and metaanalysis. Eur J. Intern Med. 2020; 82: 29-37. https://dx.doi.org/10.1016/j.ejim.2020.09.006.
- Maruhashi T., Higashi Y. Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19. Int J. Mol Sci. 2021; 22(10): 5131. https://dx.doi.org/10.3390/ijms22105131.
- Hsu J.Y., Mao Y.C., Liu P.Y., Lai K.L. Pharmacology and adverse events of emergency-use authorized medication in moderate to severe COVID-19. Pharmaceuticals (Basel). 2021; 14(10): 955. https://dx.doi.org/10.3390/ph14100955.
- Lin Z., Niu J., Xu Y. et al. Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis. J. Med Virol. 2022; 94(4): 1523-34. https://dx.doi.org/10.1002/jmv.27482.
- Ravid J.D., Leiva O., Chitalia V.C. Janus kinase signaling pathway and its role in COVID-19 inflammatory, vascular, and thrombotic manifestations. Cells. 2022; 11(2): 306. https://dx.doi.org/10.3390/cells11020306.
- Aciksari G., Cetinkal G., Kocak M. et al. Evaluation of modified ATRIA risk score in predicting mortality in hospitalized patients with COVID-19. Am J. Med Sci. 2021; 362(6): 553-61. https://dx.doi.org/10.1016/j.amjms.2021.06.001.